This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...